drugset / Trial / NCT06449352
Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost
RandomizedParallel-groupDouble-blindBasic science
Summary
A randomized, multicenter, investigator-masked prospective study of NTG patients currently on latanoprost 0.005% monotherapy, to study the effect of IOP change with the introduction of netarsudil 0.02% vs brimonidine 0.1%. Subjects will be assessed at a screening visit, and 1 follow-up visit. Clinical evaluations will include visual acuity and IOP .
Timeline
- Start
- 2024-06-13
- Primary completion
- 2025-09-22
- Completion
- 2025-09-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Brimonidine | Unknown | 0.1 % | — |
| Subject | Netarsudil | Small molecule | 0.02 % | — |